Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers

Nucleic Acids Research

Volumn 32, Issue 7, 2004, Pages 2102-2112

  Santhakumaran, Latha M ^a   Thomas, Thresia ^a   Thomas, T J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; DRUG VEHICLE; MYC PROTEIN; NANOPARTICLE; OLIGONUCLEOTIDE; PHOSPHORUS 32; POLYPROPYLENIMINE DENDRIMER; POLYPROPYLENIMINE DOTRIACONTAAMINE DENDRIMER; POLYPROPYLENIMINE HEXADECAAMINE DENDRIMER; POLYPROPYLENIMINE OCTAAMINE DENDRIMER; POLYPROPYLENIMINE TETRAAMINE DENDRIMER; POLYPROPYLENIMINE TETRAHEXACONTAAMINE DENDRIMER; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG; DNA; PHOSPHORUS; POLYPROPYLENE; TRIPLEX DNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL LEVEL; CELL TRANSPORT; CELL VIABILITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG STRUCTURE; GEL ELECTROPHORESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDRODYNAMICS; ISOTOPE LABELING; LASER; LIGHT SCATTERING; MOLECULAR SIZE; MOLECULAR WEIGHT; NONVIRAL GENE DELIVERY SYSTEM; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TIME; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; METABOLISM; NANOTECHNOLOGY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE;

MINK CELL FOCUS-FORMING VIRUS;

CELL LINE, TUMOR; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; NANOTECHNOLOGY; OLIGONUCLEOTIDES; PARTICLE SIZE; PHOSPHORUS RADIOISOTOPES; POLYPROPYLENES; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 2342565008     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh526     Document Type: Article

References (47)

1. Vijayanathan,V., Thomas,T. and Thomas,T.J. (2002) DNA nanoparticles and development of DNA delivery vehicles for gene delivery. Biochemistry, 41, 14085-14094.
2. Gewirtz,A.M., Sokol,D.L. and Ratajczak,M.Z. (1998) Nucleic acid therapeutics: state of the art and future prospects. Blood, 92, 712-730.
3. Liu,C.M., Liu,D.P. and Liang,C.C. (2002) Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy. J. Mol. Med., 80, 620-628.
4. Lebedeva,I. and Stein,C.A. (2001) Antisense oligonucleotides: promise and reality. Annu. Rev. Pharmacol. Toxicol., 41, 403-419.
5. Seidman,M.M. and Glazer,P.M. (2003) The potential for gene repair via triple helix formation. J. Clin. Invest., 112, 487-494.
6. Braasch,D.A. and Corey,D.R. (2002) Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry, 41, 4503-4510.
7. Lysik,M.A. and Wu-Pong,S. (2003) Innovations in oligonucleotide drug delivery. J. Pharm. Sci., 92, 1559-1573.
8. Dobbelstein,M. (2003) Viruses in therapy - royal road or dead end? Virus Res., 92, 219-221.
9. Hermiston,T.W. and Kuhn,I. (2002) Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Ther., 9, 1022-1035.
10. Filion,M.C. and Philips,N.C. (1998) Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm., 162, 159-170.
11. Kircheis,R., Wightman,L. and Wagner,E. (2001) Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev., 53, 341-358.
12. Boussif,O., Lezoulcqh,F., Zanta,M.A., Mergny,M.D., Scheman,D., Demeneix,B. Behr,J.P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA, 92, 7297-7301.
13. Boletta,A., Benigni,A., Lutz,J., Remuzzi,G., Soria,M.R. and Monaco,L. (1997) Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther., 8, 1243-1251.
14. Zuber,G., Dauty,E., Nothisen,M., Belguise,P. and Behr,J.P. (201) Towards synthetic viruses. Adv. Drug Deliv. Rev., 52, 245-253.
15. Godbey,W.T., Wu,K.K. and Mikos,A.G. (1999) Size matters: molecular weight affects the efficiency of poly(ethyleneimine) as a gene delivery vehicle. J. Biomed. Mater. Res., 45, 268-275.
16. Fischer,D., Bieber,T., Li,Y., Elsasser,H. and Kissel,T. (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res., 16, 1273-1279.
17. Newkome,G.R., Moorefield,C.N. and Vögtle,F. (2001) Dendrimers and Dendrons: Concepts, Synthesis, Applications. Wiley-VCH, New York.
18. Tomalia,D.A., Baker,H., Dewald,J., Hall,M., Kallos,G., Martin,S., Roeck,J., Ryder,J. and Smith,P. (1985) A new class of polymers: starbust-dendritic macromolecules. Polymer J., 17, 117-132.
19. Haensler,J. and Szöka,F. (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem., 4, 372-379.
20. DeBrabander-vandenBerg,E.M.M. and Meijer,E.M. (1993) Poly(propylene imine) dendrimers: large-scale synthesis via heterogeneously catalyzed hydrogenation. Angew. Chem., 105, 1370-1373.
21. Zinselmeyer,B.H., Mackay,S.P., Schatzlein,A.G. and Uchegbu,I.F. (2002) The lower generation poly(propylenimine) dendrimers are effective gene transfer agents. Pharm. Res., 19, 960-967.
22. Cooney,M., Czernuszewicz,G., Postel,E.H., Flint,S.J. and Hogan,M.E. (1988) Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science, 241, 456-459.
23. Thomas,R.M., Thomas,T., Wada,M., Sigal,L.H., Shirahata,A. and Thomas,T.J. (1999) Facilitation of the cellular uptake of a triplex forming oligonucleotide by novel polyamine analogues: structure-activity relationships. Biochemistry, 38, 13328-13337.
24. Thomas,T. and Thomas,T.J. (1994) Estradiol control of ornithine decarboxylase mRNA, enzyme activity and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res. Treat., 29, 189-201.
25. Vijayanathan,V., Thomas,T., Shirahata,A. and Thomas,T.J. (2001) DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry, 40, 13644-13651.
26. Baeza,I., Gariglio,P., Rangel,L.M., Chavez,P., Cervantes,L., Arguello,C., Wong,C., and Montanez,C. (1987) Electron microscopy and biochemical properties of polyamine-compacted DNA. Biochemistry, 26, 6387-6392.
27. Thomas,T.J., Faaland,C.A., Gallo,M.A. and Thomas,T. (1995) Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells. Nucleic Acids Res., 23, 3594-3599.
28. Vijayanathan,V., Thomas,T., Antony,T., Shirahata,A. and Thomas,T.J. (2004) Formation of DNA nanoparticles in the presence of novel polyamine analogues: a laser light scattering and atomic force microscopic study. Nucleic Acids Res., 32, 127-134.
29. Zuhorn,I.S., Oberle,V., Visser,W.H., Engberts,J.B., Bakowsky,U., Polushkin,E. and Hoekstra,D. (2002) Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation and transfection efficiency. Biophys. J., 83, 2096-2108.
30. Liu,G., Molas,M., Grossmann,G.A., Pasumarthy,M., Perales,J.C., Cooper,M.J. and Hanson,R.W. (2001) Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation. J. Biol. Chem., 276, 3479-3487.
31. Junghans,M., Kreuter,J. and Zimmer,A. (2001) Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. Biochim. Biophys Acta, 1544, 177-188.
32. Dauty,E., Behr,J.P. and Remy,J.S. (2002) Development of plasmid and oligonucleotide nanometric particles. Gene Ther., 9, 743-748.
33. Nguyen,T.T. and Shklovskii,B.I. (2002) Model of inversion of DNA charge by a positive polymer: fractionalization of the polymer charge. Phys. Rev. Lett., 89, 018101.
34. Choi,Y., Mecke,A., Orr,B.G., Holl,M.M.B. and Baker,J.R.,Jr (2004) DNA-directed synthesis of generation 7 and 5 PMAM dendrimer nanoclusters. Nano Lett., 4, 391-397.
35. Koper,G.J.M., van Genderen,M.H.P., Elissen-Román, Baars,M.W.P.L., Meijer,E.W. and Borkovec,M. (1997) Protonation mechanism of poly(propylenimine) dendrimers and some associated oligoamines. J. Am. Chem Soc., 119, 6512-6521.
36. Evans,H.M., Ahmad,A., Ewert,K., Pfohl,T., Martin-Herranz,A., Bruinsma,R.F. and Safinya,C.R. (2003) Structural polymorphism of DNA-dendrimer complexes. Phys. Rev. Lett., 91, 075501.
37. Saminathan,M., Thomas,T., Shirahata,A, Pillai,C.K.S. and Thomas,T.J. (2002) Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics. Nucleic Acids Res., 30, 3722-3731.
38. Tang,M. and Szöka,F. (1997) The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther., 4, 823-832.
39. Yoo,H.,R.L. and Juliano,R.L. (2000) Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res., 28, 4225-4231.
40. Bielinska,A., Kukowska-Latallo,J.F., Johnson,J., Tomalia,D.A. and Baker,J.R.,Jr (1996) Regulation of in vitro gene expression using antisense oligonucleotide or antisense expression plasmids transfected using starbust PAMAM dendrimers. Nucleic Acids Res., 24, 2176-2182.
41. Robert,J.C., Bhalgat,M.K. and Zera,R.T. (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) starbust dendrimers. J. Biomed. Mater. Res., 30, 53-65.
42. 125I-labeled polyamidoamine dendrimers in vivo. J. Control. Release, 65, 133-148.
43. Lim,Y., Kim,T., Lee,J.W., Kim,S., Kim,H., Kim,K. and Park,J. (2002) Self-assembled ternary complex of cationic dendrimer, curcurbituril and DNA: noncovalent strategy in developing a gene delivery carrier. Bioconj. Chem., 13, 1181-1185.
44. Shah,D.S., Sakthivel,T., Toth.I., Florence,A.T. and Wilderspin,A.F. (2000) DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. Int. J. Pharm., 208, 41-48.
45. Brazeau,G.A., Attia,S., Poxon,S. and Hughes,J.A. (1998) In vitro mytotoxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm. Res., 15, 680-684.
46. Kobayashi,H. and Brechbiel,M.W. (2003) Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol. Imaging, 2, 1-10.
47. 64. Cancer Res., 61, 4966-4970.